FDA Seeks Sequencing Services for Evaluation of Viral Vaccine QC Technology

The agency is requesting sequencing services on both the 454 and Illumina platforms. Beckman Coulter and Macrogen are among the companies interested in submitting proposals.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.